PPARG and type 2 diabetes mellitus: PPARs are important targets for metabolic disorders and multiple drugs targeting PPARα (fibrates, e.g., fenofibrate, bezafibrate, and clofibrate) and PPARγ (thiazolidinediones, e.g., troglitazone, rosiglitazone, pioglitazone, and ciglitazone) which have been used to treat hyperlipidemia and type 2 diabetes.